Silvercrest Asset Management Group is a New York-based boutique wealth and asset manager serving ultra-high-net-worth families, endowments, and institutions. It is a stock, not an ETF, so the $16.50 figure is an analyst price target rather than a fund objective.
The two current targets on record are $15 and $18, giving an arithmetic mean of $16.50. The low-to-high range is therefore narrow at $15 to $18, though with only two analysts contributing, the "consensus" is thin and should be treated cautiously. Reported ratings skew positive ("Buy" to "Strong Buy"), but the same limited sample means the average rating carries less weight than it would for a widely covered large-cap.
Notably, these figures represent a significant downgrade from earlier in the cycle, when targets clustered between $20 and $24. As the stock has fallen, analysts have repeatedly trimmed their expectations, a pattern that underscores the challenge of treating any single target as a firm forecast.
At a recent price of about $10, reaching $16.50 would require a move of roughly 60%. That is a very large advance for a small-cap asset manager, and it would require the shares to reclaim territory last seen in 2025. The stock's 52-week range of approximately $9.09 to $16.99 means the target sits essentially at the top of the past year's trading band.
The company is in a deliberate investment phase, hiring talent and expanding its product lineup while carrying an elevated compensation ratio of about 66% in the most recent quarter. Management has framed this spending as a foundation for margin expansion in 2027 and 2028, but the near-term result has been contracting profitability: recent quarters have missed EPS estimates, and full-year 2026 earnings estimates have been cut sharply, from about $0.80 three months ago to around $0.45 today. The path to $16.50 therefore hinges on a fundamental earnings recovery, not merely a valuation re-rating.
Several factors could support a recovery. Silvercrest has historically posted client retention in the high-90% range, reflecting deep, integrated relationships with ultra-high-net-worth families. The firm has also completed a buyback of roughly 1.5 million shares (about 17.5% of shares outstanding), reducing the share count and supporting earnings per share. A quarterly dividend of $0.21 per share translates to a yield of roughly 8% at current prices. New initiatives, including the Silvercrest Global Value Opportunity Fund and an expanded international presence in Singapore and Europe, broaden the revenue base. On valuation, the stock trades at a discount to its own historical averages and to peers, leaving room for multiple expansion if earnings stabilize.
The principal obstacle is the earnings trajectory. EPS has declined for several years, and the company has missed consensus in multiple recent quarters. Net profit margins have compressed, in part because of a shift toward lower-fee institutional mandates, while compensation and general expenses have grown faster than revenue. Net client flows have been weak, with outflows at times offsetting market gains. Finally, the dividend's payout ratio has exceeded 100%, meaning the payout is funded out of more than current earnings; if results do not recover, a dividend cut is a credible risk that could weigh on sentiment. These headwinds explain why analyst targets, though still above the current price, have been cut repeatedly.
Technically, the stock sits near the bottom of a long downtrend from its July 2023 all-time high of $23.20. The $9.00 to $9.60 zone represents the recent low and a key support area, while the $13 to $14 band — a former consolidation area — is the first meaningful resistance. Above that, the $16 to $17 region, which coincides with the 52-week high and the $16.50 target, is the principal upside hurdle. Because the stock is a low-liquidity micro-cap with modest daily volume, moves can be amplified in either direction, making technical levels less reliable than for larger, more heavily traded names.
Analyst price targets are typically based on a roughly 12-month research horizon, though with only two current targets and no detailed published rationale, the exact timeframe should not be assumed. The most important near-term catalyst is the next quarterly earnings report, expected around late October 2026. Investors should watch for signs that the compensation ratio is peaking, evidence of stabilizing or improving net flows, any revision to EPS estimates, and management commentary on whether the dividend can be maintained. Fee-rate trends and progress on the international and institutional expansion will also matter for the multi-year margin story.
Beyond traditional research, AI Daily Buy/Sell Signals from Tickeron use artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. For a volatile, thinly covered name like SAMG, this type of automated monitoring can help traders discover opportunities, keep an eye on existing positions, and spot shifting trends more efficiently than manual chart review alone. Consider exploring these signals as a complement to fundamental research.
The question of whether SAMG can reach $16.50 is ultimately a question of earnings recovery. The target — the mean of two current analyst targets of $15 and $18 — implies a roughly 60% move from a price near $10, a very large advance that would take the stock back to the top of its 52-week range. Supporters point to exceptional client retention, an aggressive buyback, an 8% dividend yield, and expansion initiatives, while skeptics highlight declining EPS, repeated quarterly misses, margin and fee pressure, weak flows, and an unsustainable payout ratio. With coverage thin and targets already cut once this cycle, the $16.50 level is best understood as a benchmark for what a successful margin turnaround could look like — not a forecast of what will happen. Watch the upcoming earnings report, expense trends, and any changes to analyst estimates before drawing conclusions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, SAMG has been loosely correlated with NEWT. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if SAMG jumps, then NEWT could also see price increases.
| Ticker / NAME | Correlation To SAMG | 1D Price Change % | ||
|---|---|---|---|---|
| SAMG | 100% | +0.91% | ||
| NEWT - SAMG | 34% Loosely correlated | -1.18% | ||
| TSLX - SAMG | 33% Poorly correlated | -1.06% | ||
| BBUC - SAMG | 33% Poorly correlated | -1.29% | ||
| WHG - SAMG | 32% Poorly correlated | -0.80% | ||
| EQH - SAMG | 31% Poorly correlated | +0.22% | ||
More | ||||